Annual Net Margin
-306.31%
+93.67%+23.42%
December 31, 2023
Summary
- As of February 7, 2025, NKTR annual net profit margin is -306.31%, with the most recent change of +93.67% (+23.42%) on December 31, 2023.
- During the last 3 years, NKTR annual net margin has fallen by -15.66% (-5.39%).
- NKTR annual net margin is now -636.54% below its all-time high of 57.09%, reached on December 31, 2018.
Performance
NKTR Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
-153.61%
+69.32%+31.09%
September 30, 2024
Summary
- As of February 7, 2025, NKTR quarterly net profit margin is -153.61%, with the most recent change of +69.32% (+31.09%) on September 30, 2024.
- Over the past year, NKTR quarterly net margin has increased by +36.24% (+19.09%).
- NKTR quarterly net margin is now -272.00% below its all-time high of 89.31%, reached on June 30, 2018.
Performance
NKTR Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
NKTR Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.4% | +19.1% |
| 3 y3 years | -5.4% | +70.5% |
| 5 y5 years | -636.5% | +54.5% |
NKTR Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +40.4% | at high | +79.2% |
| 5 y | 5-year | -5.4% | +40.4% | at high | +79.2% |
| alltime | all time | -636.5% | +40.4% | -272.0% | +79.2% |
Nektar Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -153.61%(-31.1%) |
| Jun 2024 | - | -222.93%(+31.1%) |
| Mar 2024 | - | -170.07%(-3.5%) |
| Dec 2023 | -306.31%(-23.4%) | -176.17%(-7.2%) |
| Sep 2023 | - | -189.85%(-23.9%) |
| Jun 2023 | - | -249.39%(-60.7%) |
| Mar 2023 | - | -634.52%(+134.1%) |
| Dec 2022 | -399.98%(-22.2%) | -271.03%(+8.4%) |
| Sep 2022 | - | -249.94%(-66.1%) |
| Jun 2022 | - | -736.94%(+102.4%) |
| Mar 2022 | - | -364.16%(-37.5%) |
| Dec 2021 | -514.03%(+76.9%) | -582.37%(+11.9%) |
| Sep 2021 | - | -520.47%(+17.5%) |
| Jun 2021 | - | -443.06%(-14.8%) |
| Mar 2021 | - | -520.01%(+4.1%) |
| Dec 2020 | -290.65%(-24.4%) | -499.54%(+38.2%) |
| Sep 2020 | - | -361.56%(+120.8%) |
| Jun 2020 | - | -163.78%(-40.3%) |
| Mar 2020 | - | -274.16%(-17.2%) |
| Dec 2019 | -384.47%(-773.4%) | -331.24%(-1.8%) |
| Sep 2019 | - | -337.41%(-28.7%) |
| Jun 2019 | - | -473.03%(+11.6%) |
| Mar 2019 | - | -423.90%(+71.9%) |
| Dec 2018 | 57.09%(-281.7%) | -246.60%(-28.8%) |
| Sep 2018 | - | -346.31%(-487.8%) |
| Jun 2018 | - | 89.31%(-135.4%) |
| Mar 2018 | - | -251.96%(+611.1%) |
| Dec 2017 | -31.42%(-66.1%) | -35.43%(-189.0%) |
| Sep 2017 | - | 39.80%(-123.0%) |
| Jun 2017 | - | -173.09%(-33.0%) |
| Mar 2017 | - | -258.27%(+129.2%) |
| Dec 2016 | -92.80%(+163.9%) | -112.67%(-5.3%) |
| Sep 2016 | - | -118.96%(-19.8%) |
| Jun 2016 | - | -148.32%(+348.0%) |
| Mar 2016 | - | -33.11%(-75.9%) |
| Dec 2015 | -35.17%(+30.9%) | -137.51%(+905.2%) |
| Sep 2015 | - | -13.68%(-94.1%) |
| Jun 2015 | - | -232.37%(-847.7%) |
| Mar 2015 | - | 31.08%(-113.3%) |
| Dec 2014 | -26.86%(-75.3%) | -233.65%(-539.7%) |
| Sep 2014 | - | 53.14%(-146.4%) |
| Jun 2014 | - | -114.46%(-51.0%) |
| Mar 2014 | - | -233.68%(+52.7%) |
| Dec 2013 | -108.79%(-48.6%) | -153.02%(+463.4%) |
| Sep 2013 | - | -27.16%(-78.5%) |
| Jun 2013 | - | -126.24%(-47.3%) |
| Mar 2013 | - | -239.36%(-4.4%) |
| Dec 2012 | -211.67%(+12.9%) | -250.29%(+5.8%) |
| Sep 2012 | - | -236.51%(+63.4%) |
| Jun 2012 | - | -144.76%(-36.8%) |
| Mar 2012 | - | -228.97%(-3.6%) |
| Dec 2011 | -187.43%(+685.9%) | -237.58%(+167.2%) |
| Sep 2011 | - | -88.92%(-57.6%) |
| Jun 2011 | - | -209.92%(-34.2%) |
| Mar 2011 | - | -318.91%(+540.0%) |
| Dec 2010 | -23.85%(-83.3%) | -49.83%(+116.9%) |
| Sep 2010 | - | -22.97%(+1798.3%) |
| Jun 2010 | - | -1.21%(-93.4%) |
| Mar 2010 | - | -18.44%(-6.3%) |
| Dec 2009 | -142.52% | -19.68%(-93.5%) |
| Sep 2009 | - | -302.92%(+22.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2009 | - | -246.91%(-24.6%) |
| Mar 2009 | - | -327.54%(+89.6%) |
| Dec 2008 | -38.07%(+217.3%) | - |
| Sep 2008 | - | -172.76%(+5.6%) |
| Jun 2008 | - | -163.59%(-19.7%) |
| Mar 2008 | - | -203.61%(-443.0%) |
| Dec 2007 | -12.00%(-83.1%) | 59.36%(-279.6%) |
| Sep 2007 | - | -33.06%(-20.8%) |
| Jun 2007 | - | -41.73%(+38.2%) |
| Mar 2007 | - | -30.20%(-45.7%) |
| Dec 2006 | -71.08%(-51.5%) | -55.58%(+66.2%) |
| Sep 2006 | - | -33.44%(-67.9%) |
| Jun 2006 | - | -104.33%(-9.7%) |
| Mar 2006 | - | -115.58%(-64.9%) |
| Dec 2005 | -146.59%(+64.4%) | -329.18%(+402.9%) |
| Sep 2005 | - | -65.45%(-30.6%) |
| Jun 2005 | - | -94.26%(+2.6%) |
| Mar 2005 | - | -91.83%(+49.5%) |
| Dec 2004 | -89.16%(+103.0%) | -61.44%(-14.2%) |
| Sep 2004 | - | -71.65%(-7.8%) |
| Jun 2004 | - | -77.69%(-49.8%) |
| Mar 2004 | - | -154.85%(-1229.5%) |
| Dec 2003 | -43.93%(-61.2%) | 13.71%(-121.8%) |
| Sep 2003 | - | -62.89%(+33.8%) |
| Jun 2003 | - | -46.99%(-39.9%) |
| Mar 2003 | - | -78.15%(-43.1%) |
| Dec 2002 | -113.31%(-64.9%) | -137.31%(+20.2%) |
| Sep 2002 | - | -114.23%(+2.4%) |
| Jun 2002 | - | -111.53%(+19.1%) |
| Mar 2002 | - | -93.68%(-37.6%) |
| Dec 2001 | -322.72%(+71.1%) | -150.01%(+24.8%) |
| Sep 2001 | - | -120.16%(-80.9%) |
| Jun 2001 | - | -629.76%(+9.5%) |
| Mar 2001 | - | -574.88%(+90.8%) |
| Dec 2000 | -188.66%(+102.9%) | -301.30%(+220.6%) |
| Sep 2000 | - | -93.98%(-17.7%) |
| Jun 2000 | - | -114.20%(-57.9%) |
| Mar 2000 | - | -271.16%(+75.9%) |
| Dec 1999 | -92.96%(+10.4%) | -154.12%(+134.0%) |
| Sep 1999 | - | -65.86%(+8.7%) |
| Jun 1999 | - | -60.61%(-9.7%) |
| Mar 1999 | - | -67.13%(-32.5%) |
| Dec 1998 | -84.22%(+37.1%) | -99.39%(-2.6%) |
| Sep 1998 | - | -102.04%(+139.1%) |
| Jun 1998 | - | -42.67%(-60.3%) |
| Mar 1998 | - | -107.35%(+72.0%) |
| Dec 1997 | -61.44%(-57.6%) | -62.42%(+1.5%) |
| Sep 1997 | - | -61.52%(+6.4%) |
| Jun 1997 | - | -57.84%(-10.1%) |
| Mar 1997 | - | -64.34%(-58.4%) |
| Dec 1996 | -144.93%(-36.0%) | -154.55%(+21.0%) |
| Sep 1996 | - | -127.78%(-28.4%) |
| Jun 1996 | - | -178.57%(+41.0%) |
| Mar 1996 | - | -126.67%(-55.9%) |
| Dec 1995 | -226.47%(-27.4%) | -287.50%(+69.1%) |
| Sep 1995 | - | -170.00%(+6.3%) |
| Jun 1995 | - | -160.00%(-56.4%) |
| Mar 1995 | - | -366.67%(-20.3%) |
| Dec 1994 | -311.76% | -460.00%(+206.7%) |
| Sep 1994 | - | -150.00%(-50.0%) |
| Jun 1994 | - | -300.00%(+9.1%) |
| Mar 1994 | - | -275.00% |
FAQ
- What is Nektar Therapeutics annual net profit margin?
- What is the all time high annual net margin for Nektar Therapeutics?
- What is Nektar Therapeutics annual net margin year-on-year change?
- What is Nektar Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly net margin year-on-year change?
What is Nektar Therapeutics annual net profit margin?
The current annual net margin of NKTR is -306.31%
What is the all time high annual net margin for Nektar Therapeutics?
Nektar Therapeutics all-time high annual net profit margin is 57.09%
What is Nektar Therapeutics annual net margin year-on-year change?
Over the past year, NKTR annual net profit margin has changed by +93.67% (+23.42%)
What is Nektar Therapeutics quarterly net profit margin?
The current quarterly net margin of NKTR is -153.61%
What is the all time high quarterly net margin for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly net profit margin is 89.31%
What is Nektar Therapeutics quarterly net margin year-on-year change?
Over the past year, NKTR quarterly net profit margin has changed by +36.24% (+19.09%)